Loading…
Clover Health Investments, Corp. is projected to rise to $5.39 by 2027, a +21% move from its current price of $4.44. CLOV is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $4.29 | $4.44 | $4.60 | +0.08% |
| Jul 14 | $4.23 | $4.45 | $4.68 | +0.17% |
| Jul 15 | $4.19 | $4.45 | $4.73 | +0.25% |
| Jul 16 | $4.15 | $4.45 | $4.78 | +0.33% |
| Jul 17 | $4.12 | $4.46 | $4.83 | +0.42% |
| Jul 18 | $4.09 | $4.46 | $4.87 | +0.50% |
| Jul 19 | $4.07 | $4.47 | $4.91 | +0.59% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.07 | $4.47 | $4.91 | +0.59% |
| Week 2 | $3.93 | $4.49 | $5.13 | +1.17% |
| Week 3 | $3.84 | $4.52 | $5.32 | +1.77% |
| Week 4 | $3.77 | $4.54 | $5.48 | +2.36% |
| Week 5 | $3.71 | $4.57 | $5.64 | +2.96% |
| Week 6 | $3.65 | $4.60 | $5.79 | +3.56% |
| Week 7 | $3.61 | $4.63 | $5.93 | +4.17% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Clover Health Investments, Corp. operates in the Healthcare sector. The company provides medicare advantage plans in the United States and offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals.
It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
CLOV is the Clover Health Investments, Corp. stock. The current price is $4.44 and the market cap is $2.34B, with a rank of 1926. These metrics place the equity among a wide field of small- to mid-cap healthcare stocks.
The price outlook shown by the year-by-year forecast points to meaningful upside over time, with the average price rising across multiple years.
A major floor 61.7% below — a decisive break under it would weaken the trend.
The nearest floor, 17.8% below — buyers have tended to step in here.
The nearest ceiling, 21.8% above — a clean break opens room to run.
A major ceiling 41.0% above — clearing it would confirm fresh momentum.
Key CLOV support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CLOV market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.77 | Sell | $4.73 | Sell |
| MA 10 | $5.04 | Sell | $4.88 | Sell |
| MA 20 | $5.01 | Sell | $4.81 | Sell |
| MA 50 | $4.09 | Buy | $4.19 | Buy |
| MA 100 | $3.06 | Buy | $3.55 | Buy |
| MA 200 | $2.86 | Buy | $3.15 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.00 | Neutral |
| Stoch RSI (14) | 0.00 | Buy |
| CCI (20) | -176.29 | Sell |
| Williams %R (14) | -100.00 | Info |
| MACD (12,26,9) | -0.15 | Sell |
| ROC (12) | -12.25 | Sell |
| Bollinger %B (20,2) | -0.05 | Buy |
| Stochastic %K (14) | 0.00 | Buy |
| TRIX (15) | 1.19 | Buy |
| Awesome (5,34) | 0.21 | Buy |
| Ultimate (7,14,28) | 26.42 | Buy |
| Momentum (10) | -0.77 | Sell |
| Aroon Osc (25) | 64.00 | Buy |
| Hull MA (9) | 4.49 | Sell |
| ADX (14) | 33.78 | Sell |
| ATR (14) | 0.15 | Info |
The 30-day technical picture shows a bullish tilt despite a modest RSI14 of 40. The stock trades with SMA50 at $4.09 and SMA200 at $2.86, and the current price of $4.44 sits above both moving averages. The 30-day range runs from $3.51 to $5.61, with near-term support seen at $3.65 and resistance at $5.41.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.70 | $4.44 | $6.18 | 0% | Neutral | |
| $4.17 | $5.39 | $7.43 | +21% | Bullish | |
| $4.60 | $6.17 | $8.91 | +39% | Bullish | |
| $6.01 | $8.32 | $12.45 | +87% | Bullish | |
| $7.57 | $10.77 | $16.61 | +143% | Bullish | |
| $8.69 | $12.68 | $20.08 | +186% | Bullish | |
| $9.50 | $14.21 | $23.02 | +220% | Bullish | |
| $10.08 | $15.42 | $25.50 | +247% | Bullish | |
| $10.60 | $16.57 | $27.94 | +273% | Bullish | |
| $11.45 | $18.26 | $31.35 | +311% | Bullish | |
| $18.15 | $31.88 | $58.91 | +618% | Bullish | |
| $40.73 | $85.05 | $174.70 | +18.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.70 | $4.44 | $5.35 | +0.00% |
| August 2026 | $3.80 | $4.53 | $5.55 | +1.93% |
| September 2026 | $3.99 | $4.79 | $5.96 | +5.86% |
| October 2026 | $4.06 | $4.92 | $6.19 | +2.62% |
| November 2026 | $3.94 | $4.80 | $6.10 | -2.44% |
| December 2026 | $3.92 | $4.81 | $6.18 | +0.31% |
Click any year to see its month-by-month CLOV forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, CLOV could reach as high as $6.18, with a base case around $4.44 and support toward $1.70 — roughly 0% from $4.44. A consolidation phase looks the most probable path here.
Expect CLOV to range from $4.17 to $7.43 through 2027. The $5.39 average target implies a +21% move from current prices. That is up +21% on the projected 2026 average. Momentum favours further upside here.
The CLOV price prediction for 2028 points to an average of $6.17 (low $4.60, high $8.91) — a potential gain of +39% on today's $4.44. Buyers look set to stay in control over this stretch.
In 2029, CLOV is projected to trade between $6.01 and $12.45, averaging $8.32 — a potential gain of +87% from today's $4.44. That is up +35% on the projected 2028 average. Momentum favours further upside here.
Clover Health Investments, Corp.'s 2030 outlook centres on $10.77, within a $7.57 to $16.61 range. That is up +30% on the projected 2029 average. That marks a +143% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, CLOV could reach as high as $20.08, with a base case around $12.68 and support toward $8.69 — roughly +186% from $4.44. Momentum favours further upside here.
Expect CLOV to range from $9.50 to $23.02 through 2032. The $14.21 average target implies a +220% move from current prices. That is up +12% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The CLOV price prediction for 2033 points to an average of $15.42 (low $10.08, high $25.50) — a potential gain of +247% on today's $4.44. Momentum favours further upside here.
In 2034, CLOV is projected to trade between $10.60 and $27.94, averaging $16.57 — a potential gain of +273% from today's $4.44. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Clover Health Investments, Corp.'s 2035 outlook centres on $18.26, within a $11.45 to $31.35 range. That is up +10% on the projected 2034 average. That marks a +311% change versus current levels. Momentum favours further upside here.
By 2040, CLOV could reach as high as $58.91, with a base case around $31.88 and support toward $18.15 — roughly +618% from $4.44. Buyers look set to stay in control over this stretch.
Expect CLOV to range from $40.73 to $174.70 through 2050. The $85.05 average target implies a +18.2x move from current prices. That is up +167% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in CLOV today (≈ 225.225225 CLOV) could be worth
$19,155.73
+$18,155.73 (+1816%) by 2050 · US Dollar
Based on the average projected CLOV price of $85.05 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CLOVwould be worth at today's price.
$1,000 invested in CLOV on Jul 10, 2025 (≈ 327.868858 CLOV) would be worth
$1,455.74
+$455.74 (+45.6%) today · 1.46× · US Dollar
Based on a CLOV entry price of $3.05 vs. today's $4.44.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $5.26 | $844.11 | -15.6% |
| 1 month ago | $4.89 | $907.98 | -9.2% |
| 3 months ago | $1.93 | $2,300.52 | +130.1% |
| 6 months ago | $2.64 | $1,681.82 | +68.2% |
| 1 year ago | $3.05 | $1,455.74 | +45.6% |
| All time (5.0y) ago | $8.91 | $498.32 | -50.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CLOV forecast.
Our base-case forecast reaches $8.90 around 2030.
Implied market cap at $8.90: $3.84B
The multi-year forecast envisions substantial upside. In 2030 the average price is projected at $10.77 with a min of $7.57 and a max of $16.62, yielding a 142.7 ROI and a bullish sentiment. The 2040 forecast shows an average price of $31.88 (min $18.15, max $58.91) with a 618.1 ROI and a bullish stance.
By 2050, the average is $85.11 (min $40.75, max $174.83) and the ROI reaches 1816.9 with continued bullish sentiment. These figures illustrate a long-run path of growth, albeit with the usual uncertainty and the forecasted outcomes should be regarded as estimates, not guarantees.
Tap a question to reveal the answer.
Average price $10.77; Min $7.57; Max $16.62; ROI 142.7; sentiment BULLISH.
In 2026 the average price is $4.44 with ROI 0 and sentiment NEUTRAL; from 2027 onward the forecast shows bullish momentum with rising averages and ROIs.
Yes, the forecasted maximum for 2050 is $174.83.
Sentiment BULLISH; RSI14 is 40; SMA50 is $4.09; SMA200 is $2.86; current price $4.44; 30-day range $3.51–$5.61; support $3.65; resistance $5.41.
Healthcare.
Clover Health Investments, Corp. Community Discussion
0Share your Clover Health Investments, Corp. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.